BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 5, 2018
View Archived Issues
Germline variants, tumor variation
Read More
Monalizumab's mysteries
Read More
Placenta organoids to give insights into pregnancy's mysteries
Read More
Advanced Accelerator Applications and Fujifilm Toyama sign license agreement for FF-10158 for cancer
Read More
Novo Nordisk initiates phase II study of once-weekly insulin 287 in type 2 diabetes
Read More
Oryzon initiates phase IIa study of iadademstat in second-line SCLC
Read More
Calygene Biotechnology patents new ML1 antagonists
Read More
University of Pennsylvania divulges anti-PF-4 antibodies
Read More
aTyr Pharma initiates phase Ib/IIa study of ATYR-1923 in patients with pulmonary sarcoidosis
Read More
University of Louisville stem cell-derived exosomes for cancer
Read More
ALLO-715 CAR T cells exhibit antitumor potency in in vitro and in vivo models of R/R MM
Read More
New PROTAC DT-2216 shows promising preclinical activity against BCL-X(L)-dependent tumors
Read More
Novel degraders of IRAK-4 demonstrate promising preclinical activity in ABC-DLBCL models
Read More
GRB10 identified as a novel therapeutic target in AML
Read More
DCB-HDG2-411 shows promising preclinical activity for Hh pathway-driven cancers
Read More
GPA-500 reduces tumor growth in models of enzalutamide-resistant prostate cancer
Read More
Exelixis and Ipsen initiate COSMIC-312 phase III study of cabozantinib plus atezolizumab in HCC
Read More
Aridis announces new milestones in AR-501 development
Read More
Faron identifies optimal subgroup of patients for Traumakine treatment in INTEREST study
Read More
First patient dosed in phase II study of MEDI-0457 plus durvalumab in HPV-associated cancers
Read More
Carnot Biosciences and HemoShear Therapeutics to develop protein-based therapeutics
Read More
PersImmune presents first-in-human data for PACTN in MDS
Read More
FLT180a gene therapy safe in first two hemophilia B patients in clinical trial
Read More
Hookipa Biotech initiates phase II study of HB-101 in kidney transplant patients
Read More
ImmuneMed initiates phase I study of hzVSF-v13
Read More
Cytokinetics begins clinical testing of CK-3773274
Read More